GenSight Biologics issues 26,478,004 shares via fundraising with warrants attached

• GenSight Biologics issued 11,940,300 pre-funded warrants exercisable into 11,940,300 ordinary shares at an exercise price of EUR 0.01.
• It also issued 14,537,704 investor warrants exercisable into 7,268,852 ordinary shares at EUR 0.0497 per warrant, or EUR 0.0994 per share.
• Both warrant series can be exercised at any time within 60 months of issuance.
• Full exercise would raise additional gross proceeds of EUR 841,926.8888, including EUR 722,523.8888 from investor warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gensight Biologics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261007822305) on October 08, 2026, and is solely responsible for the information contained therein.